
亚太地区生物制药冻干服务市场预测至 2028 年 - COVID-19 影响和区域分析 - 按服务类型(冻干周期开发、临床制造、商业制造和冷冻干燥分析服务)和最终用户(制药和生物技术公司、研究)研究所及其他)
No. of Pages: 101 | Report Code: BMIRE00028758 | Category: Life Sciences
No. of Pages: 101 | Report Code: BMIRE00028758 | Category: Life Sciences
冻干服务市场的生物制药公司正在推出先进的冻干技术,以扩大业务并保持市场竞争环境。 2022年8月,通过ISO认证的合同开发和制造组织(CDMO),为体外诊断(IVD)产品提供从开发到制造过程的一体化服务的Leadgene Biomedical, Inc.推出了LEADSPHERE冻干技术。该技术有助于分配、储存和运输生物分子分析工具中使用的试剂。它还允许检测试剂在室温下以非液体形式保持稳定,并能够通过“拾取和放置”自动化系统以大规模生产方式组装完整的试剂盒。使用 LEADSPHERE 冻干技术的一个成功例子是 LEADSPHERE 蛋白酶 K,它是一种内肽酶,用于通过灭活核糖核酸酶和消化蛋白质来制备核酸样品。 LEADSPHERE 蛋白酶 K 已用于检测病毒,例如 SARS-CoV-2。
2022 年 5 月,全球领先的 CDMO PCI Pharma Services (PCI)宣布大幅扩大无菌冻干技术和无菌液体灌装技术的产能和能力——注射剂和生物疗法常用的重要制造工艺——投资 1 亿美元用于建设和增强世界一流的工厂新罕布什尔州贝德福德校区的设施。该设施将采用最先进的技术,包括带有完全隔离的安全壳系统的无菌灌装生产线。此外,它将容纳带有自动装载和卸载系统的双冻干机,能够在无菌灌装生产线上每分钟完成 400 瓶。
这种先进冻干技术的推出技术可能会为亚太地区生物制药冻干服务市场的参与者提供机会,使其在未来几年内获得重要地位。
亚太地区是全球生物制药冻干服务增长最快的市场。亚太地区市场分为中国、印度、日本、澳大利亚、韩国和亚太其他地区。中国、日本和印度对市场增长做出了广泛贡献。这些国家生物制药产品产量的增加可能需要冻干服务。此外,国内公司投资的增加预计将影响预测期内的市场增长。
另一方面,韩国和澳大利亚等国家提供了重要的增长机会由于临床试验不断增加。不断增加的研发投资可能会促进市场增长。
亚太地区生物制药市场冻干服务细分
亚太地区生物制药冻干服务市场细分为服务类型、最终用户和国家/地区。
根据服务类型,亚太地区生物制药市场冻干服务分为冻干循环开发、临床制造、商业制造和冻干分析服务。 2023年,商业制造领域在亚太地区生物制药冻干服务市场中占据最大份额。
按最终用户划分,亚太地区生物制药冻干服务市场细分进入制药业生物技术公司、研究机构等。制药及2023年,生物技术公司细分市场在亚太地区生物制药冻干服务市场中占据最大份额。
按国家/地区划分,亚太地区生物制药冻干服务市场细分为中国、日本、印度、韩国、澳大利亚和亚太地区其他地区。 2023 年,中国在亚太地区生物制药冻干服务市场占据主导地位。
Curia Global Inc、Emergent BioSolutions Inc、Jubilant HollisterStier LLC. 和 PCI Pharma Services是亚太地区生物制药市场冻干服务的领先公司。
Strategic insights for Asia Pacific Lyophilization Services for Biopharmaceuticals involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 334.18 Million |
Market Size by 2028 | US$ 551.97 Million |
Global CAGR (2023 - 2028) | 10.6% |
Historical Data | 2021-2022 |
Forecast period | 2024-2028 |
Segments Covered |
By 服务类型
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Lyophilization Services for Biopharmaceuticals refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Lyophilization Services for Biopharmaceuticals Market is valued at US$ 334.18 Million in 2023, it is projected to reach US$ 551.97 Million by 2028.
As per our report Asia Pacific Lyophilization Services for Biopharmaceuticals Market, the market size is valued at US$ 334.18 Million in 2023, projecting it to reach US$ 551.97 Million by 2028. This translates to a CAGR of approximately 10.6% during the forecast period.
The Asia Pacific Lyophilization Services for Biopharmaceuticals Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Lyophilization Services for Biopharmaceuticals Market report:
The Asia Pacific Lyophilization Services for Biopharmaceuticals Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Lyophilization Services for Biopharmaceuticals Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Lyophilization Services for Biopharmaceuticals Market value chain can benefit from the information contained in a comprehensive market report.